2.2 Million Doses of Covid-19 Vaccine Arrive in Ethiopia

Addis Ababa: Ethiopia has received 2.184 million doses of the Astra Zeneca cobid -19 vaccine via the COVAX Facility. 
 
This delivery is part of the first wave of arrivals of the covid-19 vaccines in Ethiopia that will continue in the coming weeks.
 
The Astra Zeneca vaccines licensed and manufactured by Serum Institute of India (SII) were delivered by Ethiopian Airlines at Bole International Airport on Sunday morning. 

On hand to receive the shipment were Dr Lia Tadesse, Minister of Health, Yasmin Wohabrebbi, State Minister of Finance and  Economic Cooperation, the WHO Representative Dr Boureima Hama Sambo, UNICEF Representative Adele Khodr and development partners.
 
"Were very pleased that Ethiopia is receiving its first COVAX vaccine doses," said Charlie Whetham, Regional Head, Asia Pacific and Anglophone Africa at Gavi, the Vaccine Alliance, in a press release on Sunday,
 
"Thanks to the work of the Government of Ethiopia and of the COVAX partners, and with the support of our donors, we're delivering on our promise to begin vaccinating vulnerable populations around the world," Whetham stated.
 
This is among the first shipments to countries in the WHO African Region by the COVAX Facility in its unprecedented effort to deliver at least 2 billion doses of covid-19 vaccines by the end of 2021.
 
This shipment contains 2,184,000 doses of Astra Zeneca vaccines. 
 
It is the first of several shipments that will be delivered to Ethiopia in accordance with global vaccine availability and the Ethiopia National Deployment and Vaccination Plan (NDVP). 
 
Vaccinations will commence in the next few days for the first phase priority groups.
 
COVAX is part of the Access to Covid-19 Tools (ACT) Accelerator, a ground-breaking global collaboration to accelerate development, production, and equitable access to covid-19 tests, treatments, and vaccines. 
 
COVAX is co-led by Gavi, the Vaccine Alliance, the World health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI), working in partnership with UNICEF as well as the World Bank, civil society organisations, manufacturers, and development partners. 
 
COVAX has built a diverse portfolio of vaccines suitable for a range of settings and populations, and is on track to meet its goal of delivering at least 2 billion doses of vaccine to participating countries around the globe in 2021, including at least 1.3 billion donor-funded doses to the 92 lower-income COVAX Facility participants supported by the Gavi COVAX AMC.
 
Cek Berita dan Artikel yang lain di Google News